Biotech Showcase 2012_AlloCure – Video

Posted: Published on January 30th, 2013

This post was added by Dr. Richardson




Biotech Showcase 2012_AlloCure
AlloCure, Inc. is a pioneer in the development of cell therapies for the treatment of kidney disease and is a leader in the acute kidney injury field. The company #39;s proprietary technology enables the isolation and expansion of mesenchymal stem cells (MSC), obtained via conventional bone marrow donation, which can then be administered off-the-shelf to any patient in need without requiring tissue matching or immunosuppressants. The company #39;s most advanced program, AC607, targeting acute kidney injury, is entering phase 2 clinical development and represents the first cell therapy to treat this life threatening condition. http://www.allocure.com View AlloCure #39;s Alliance for Regenerative Medicine member profile at alliancerm.org

By: AllianceRegenMed

See more here:
Biotech Showcase 2012_AlloCure - Video

Related Posts
This entry was posted in Mesenchymal Stem Cells. Bookmark the permalink.

Comments are closed.